Galera therapeutics reports q1 loss per share of $0.74

Galera therapeutics reports first quarter 2020 financial results and provides business updates.q1 loss per share $0.74.galera therapeutics - roman phase 3 trial topline data readout guidance updated to 2h21 due to impact of covid-19.galera therapeutics - amendment to royalty agreement for additional $37.5mln extends cash runway into 2h22.

GRTX Ratings Summary

GRTX Quant Ranking